Influence of treatment with tamoxifen an
โ
Svein I. Helle; Jeff M. P. Holly; Michael Tally; Kerstin Hall; Jos Van Der Stapp
๐
Article
๐
1996
๐
John Wiley and Sons
๐
French
โ 540 KB
Plasma levels of IGF-I, IGFBP-I and IGFBP-3 were measured before and during treatment with tamoxifen up to 19+ months in 34 post-menopausal patients with advanced breast cancer. In 28 patients, pro-IGF-IIE (IGF-IIE) levels were determined and IGFBP-3 was evaluated by immunoblot in 27 patients. Tamox